Capricorn Fund Managers’s AbbVie ABBV Stock Holding History

Capricorn Fund Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.96M	Buy	+27,397	New	+$6.08M	0.93%	36
2025 Q4	–	Sell	-29,535	Closed	-$6.84M	–	83
2025 Q3	$6.84M	Sell	29,535 -1,859	-6%	-$379K	2.3%	16
2025 Q2	$5.83M	Sell	31,394 -2,824	-8%	-$525K	2.75%	15
2025 Q1	$7.17M	Buy	34,218 +208	+0.6%	+$40.4K	3.83%	9
2024 Q4	$5.99M	Sell	34,010 -188	-0.5%	-$34.6K	2.67%	12
2024 Q3	$6.75M	Buy	34,198 +8,751	+34%	+$1.63M	4.55%	6
2024 Q2	$4.36M	Hold	25,447	–	–	3.08%	13
2024 Q1	$4.63M	Hold	25,447	–	–	2.79%	13
2023 Q4	$3.94M	Buy	+25,447	New	+$3.71M	2.17%	17

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capricorn Fund Managers's ABBV Position: Q1 2026 in Review

Capricorn Fund Managers opened a new position in AbbVie (ABBV) in Q1 2026: 27,397 shares worth $5.96M. The stake represents 0.93% of the portfolio and ranks #36 among its holdings. This is a return to the name: Capricorn Fund Managers previously reported a position in ABBV as recently as Q3 2025.

Capricorn Fund Managers first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.17M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Capricorn Fund Managers held 27,397 shares of AbbVie worth $5.96M as of Q1 2026.
AbbVie was a new Capricorn Fund Managers position in Q1 2026.
AbbVie made up 0.93% of Capricorn Fund Managers's portfolio in Q1 2026, its #36 holding.
Capricorn Fund Managers first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
Capricorn Fund Managers's AbbVie position peaked at $7.17M in Q1 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capricorn Fund Managers's 13F filing for Q1 2026, filed 24 Apr 2026.